SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Gross Margin
SK Biopharmaceuticals Co Ltd

91.1%
Current
91%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
91.1%
=
Gross Profit
423.6B
/
Revenue
465.1B

Gross Margin Across Competitors

Country KR
Market Cap 8.1T KRW
Gross Margin
91%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 364.1B USD
Gross Margin
69%
Country US
Market Cap 248.4B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for SK Biopharmaceuticals Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
91.1%
=
Gross Profit
423.6B
/
Revenue
465.1B
What is the Gross Margin of SK Biopharmaceuticals Co Ltd?

Based on SK Biopharmaceuticals Co Ltd's most recent financial statements, the company has Gross Margin of 91.1%.